Our Team
Mr. Cothrel has 25+ years in medtech general management, development/commercialization, operations, and strategy. After starting at Abbott Laboratories, he rose to a VP/corporate officer role with Roche prior to founding Blue Marble Medical, where he has had CEO roles at 4 medtech newcos and taken governance or advisory roles in many others.
Dr. von Allmen is the Surgeon-in-Chief; Lester W. Martin Chair of Pediatric Surgery and Senior Vice President, Surgical Services at Cincinnati Children's Hospital Medical Center, where he also holds an academic appointment as a Professor, University of Cincinnati Department of Surgery. His special clinical interests include pediatric surgical oncology, inflammatory bowel disease, surgical innovation, and surgical robotics. He conceived the FIND system.
Dr. Guterman is with Ben Gurion University where he is a Professor in the Department of Electrical and Computer Engineering and a Researcher in Agricultural, Biological, and Cognitive robotics. He is an expert in autonomous robotics and is the technical visionary behind bringing Dr. von Allmen's concept to life.
Mr. Dunki-Jacobs has over 40 years of industry experience as a technical and business development leader with General Electric and Johnson and Johnson; President of Xi Technology, LLC, a life sciences and medical device business development and consulting firm.
Ms. Dickerson has a proven track record of successfully developing, implementing and managing Quality Management Systems from design to customer delivery in both medical and consumer applications for P&G, Spectrum Brands, and Energizer Holdings.
Additional Directors
Director of life sciences at CincyTech, Dr. Rice has 27 years of venture investing and 13 years of research and R&D management experience in biomedical science. He has been co-founder and Managing Partner of Triathlon Medical Ventures; a Managing Director of Senmed Medical Ventures; and involved in research, research management, and business development with Battelle Memorial Institute. He serves on the Boards of Aerpio Therapeutics, Eccrine Systems, and is Chairman of Airway Therapeutics.
Mr. Peleg is the CEO of BGN Technologies, the technology transfer company of Ben-Gurion University. Prior to his role at BGN, Josh was the CEO of Zeraim Gedera and Head of the Commercial Unit for Syngenta Israel. He has had international roles at the Foreign Trade Administration at the Israeli Ministry of Industry, Trade, and Labor. Mr. Peleg represents BBN on Xact's Board.